Reynolds American Inc. has achieved a legal victory in a case involving e-cigarette technology that was being reviewed by the US Patent and Trademark Office.
The Patent Trial and Appeal Board of the organization ruled on September 8th that 13 disputed patent claims of Philip Morris Products SA regarding the "556" patent were deemed "unpatentable.
RJ Reynolds Vapor Co., along with RAI Innovations Co., RJ Reynolds Tobacco Co., and Reynolds Asia-Pacific Ltd., has jointly challenged Philip Morris' patent.
The board of directors held a hearing on July 7th. A panel composed of three judges stated that this was their final written decision on the matter.
According to the ruling, Patent No. 556 is dedicated to the pod of an aerosol generation system, particularly an electric smoking system.
Reynolds' accusation is based on the patent law's obviousness clause.
According to Berks IP law firm, "When a patent is obvious, it means that ordinary skilled persons in the field would know how to combine two or more existing technical references to disclose each aspect of the patent claims.
Philip Morris International (PMI) stated in a press release that they are reviewing the decision and considering their next possible actions, as the decision may be subject to an appeal.
Statement:
This article has been compiled from third-party information and is intended for industry exchange and learning purposes only.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truth or accuracy of its content. The translation of this article is only for the purpose of industry communication and research.
Due to limitations in our translation skills, the translated article may not necessarily fully convey the meaning of the original text. Hence, we advise readers to rely on the original text for accurate information.
2FIRSTS maintains complete consistency with the Chinese government regarding all domestic, Hong Kong, Macau, Taiwan, and foreign related statements and positions.
The copyright of compiled information belongs to the original media and author, and if there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
